|
Tabla 4: NT-Pro-BNP y LRA. |
|||||||
|
NT-Pro-BNP |
< 500 ng/dL n (%) |
501-1,000 ng/dL n (%) |
1,001-1,500 ng/dL n (%) |
1,501-2,000 ng/dL n (%) |
> 2,000 ng/dL n (%) |
Total n (%) |
Signi- ficancia |
|
LRA |
28 (60.9) |
9 (52.9) |
4 (66.7) |
5 (50.0) |
15 (75.0) |
61 (61.6) |
0.61 |
|
Grado de LRA |
|||||||
|
Sin lesión |
14 (30.4) |
5 (29.4) |
2 (33.3) |
5 (50.0) |
2 (10.0) |
28 (28.3) |
0.00* |
|
AKIN 1 |
24 (52.2) |
7 (41.2) |
1 (16.7) |
1 (10.0) |
5 (25.0) |
38 (38.4) |
|
|
AKIN 2 |
5 (10.9) |
4 (23.5) |
3 (50.0) |
2 (20.0) |
5 (25.0) |
19 (19.2) |
|
|
AKIN 3 |
3 (6.5) |
1 (5.9) |
0 (0.0) |
2 (20.0) |
8 (40.0) |
14 (14.1) |
|
|
TRRC |
4 (8.7) |
0 (0.0) |
0 (0.0) |
0 (0.0) |
4 (20.0) |
8 (8.1) |
0.15 |
|
* Valor de p significativo, LRA = lesión renal aguda. |
|||||||